Related Experiment Video
Updated: May 2, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Screening process failures for hepatocellular carcinoma
Amit G Singal1, Jorge A Marrero, Adam Yopp
1From the aDepartment of Internal Medicine, UT Southwestern Medical Center and Parkland Health Hospital System; bHarold C. Simmons Cancer Center, UT Southwestern Medical Center; and Departments of cClinical Sciences and dSurgery, University of Texas Southwestern, Dallas, Texas.
Most hepatocellular carcinoma (HCC) patients miss screening steps, with lack of surveillance being the primary failure. Improving HCC screening is crucial for earlier detection and better survival outcomes.
Area of Science:
- Hepatology
- Oncology
- Public Health
Background:
- Hepatocellular carcinoma (HCC) diagnosis often occurs at late stages, indicating significant failures in the patient screening process.
- Effective interventions require understanding specific breakdowns within the HCC surveillance pathway.
Purpose of the Study:
- To characterize failures in the hepatocellular carcinoma (HCC) screening process among patients with cirrhosis.
- To identify predictors of these screening process failures.
Main Methods:
- Retrospective cohort study of 185 patients with cirrhosis diagnosed with HCC between 2005 and 2012.
- Screening failures categorized as absence of surveillance, failure of detection, or delayed follow-up.
- Univariate and multivariate analyses used to determine predictors of screening failures.
Main Results:
- Only 8.6% of patients completed the HCC screening process successfully.
- Absence of surveillance was the most common failure (75.7%), associated with trends toward lower early detection and worse survival.
- Failure of detection and delayed follow-up occurred in 11.4% and 2.7% of patients, respectively.
Conclusions:
- Significant gaps exist in the HCC screening process, particularly the absence of surveillance.
- Addressing these screening failures is essential for improving early diagnosis and patient outcomes in hepatocellular carcinoma.
More Related Videos
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
07:25Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023